Literature DB >> 18063691

Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family peptide receptor 2.

Angela Manegold Svendsen1, Milka Vrecl, Tina M Ellis, Anders Heding, Jesper Bøggild Kristensen, John D Wade, Ross A D Bathgate, Pierre De Meyts, Jane Nøhr.   

Abstract

Insulin-like peptide 3 (INSL3) binds to a G protein-coupled receptor (GPCR) called relaxin family peptide receptor 2 (RXFP2). RXFP2 belongs to the leucine-rich repeat-containing subgroup (LGR) of class A GPCRs. Negative cooperativity has recently been demonstrated in other members of the LGR subgroup. In this work, the kinetics of INSL3 binding to HEK293 cells stably transfected with RXFP2 (HEK293-RXFP2) have been investigated in detail to study whether negative cooperativity occurs and whether this receptor functions as a dimer. Our results show that negative cooperativity is present and that INSL3-RXFP2 binding shows both similarities and differences with insulin binding to the insulin receptor. A dose-response curve for the negative cooperativity of INSL3 binding had a reverse bell shape reminiscent of that seen for the negative cooperativity of insulin binding to its receptor. This suggests that binding of INSL3 may happen in a trans rather than in a cis way in a receptor dimer. Bioluminescence resonance energy transfer (BRET(2)) experiments confirmed that RXFP2 forms constitutive homodimers. Heterodimerization between RXFP2 and RXFP1 was also observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063691     DOI: 10.1210/en.2007-0412

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.

Authors:  András Kern; Gillian D Bryant-Greenwood
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

Review 3.  Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.

Authors:  Michelle L Halls
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  The minimal active structure of human relaxin-2.

Authors:  Mohammed Akhter Hossain; K Johan Rosengren; Chrishan S Samuel; Fazel Shabanpoor; Linda J Chan; Ross A D Bathgate; John D Wade
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

5.  Evidence for aggregation of protein kinase CK2 in the cell: a novel strategy for studying CK2 holoenzyme interaction by BRET(2).

Authors:  Gerda M Hübner; Jane Nøhr Larsen; Barbara Guerra; Karsten Niefind; Milka Vrecl; Olaf-Georg Issinger
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

Review 6.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Solution structure of a conformationally restricted fully active derivative of the human relaxin-like factor.

Authors:  Erika E Büllesbach; Mathias A S Hass; Malene R Jensen; D Flemming Hansen; Søren M Kristensen; Christian Schwabe; Jens J Led
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

8.  The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.

Authors:  Roy C K Kong; Emma J Petrie; Biswaranjan Mohanty; Jason Ling; Jeremy C Y Lee; Paul R Gooley; Ross A D Bathgate
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

9.  Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity.

Authors:  Sarah Norklit Roed; Anne Orgaard; Rasmus Jorgensen; Pierre De Meyts
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-07       Impact factor: 5.555

10.  Analgesic effect of central relaxin receptor activation on persistent inflammatory pain in mice: behavioral and neurochemical data.

Authors:  Cynthia Abboud; Louison Brochoire; Adèle Drouet; M Akhter Hossain; Walid Hleihel; Andrew L Gundlach; Marc Landry
Journal:  Pain Rep       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.